2024 annual financial data
HCW Biologics 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -554.29%.
Operating income was -29,479,667 USD and net income was -30,023,814 USD.
Operating cash flow was -14,227,428 USD.
Get free HCW Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,566,792 USD
- Operating income
- -29,479,667 USD
- Net income
- -30,023,814 USD
- Operating cash flow
- -14,227,428 USD